EP1061908A4 - Therapie associee destinee au syndrome ischemique coronarien aigu ainsi qu'a des troubles connexes - Google Patents

Therapie associee destinee au syndrome ischemique coronarien aigu ainsi qu'a des troubles connexes

Info

Publication number
EP1061908A4
EP1061908A4 EP99911208A EP99911208A EP1061908A4 EP 1061908 A4 EP1061908 A4 EP 1061908A4 EP 99911208 A EP99911208 A EP 99911208A EP 99911208 A EP99911208 A EP 99911208A EP 1061908 A4 EP1061908 A4 EP 1061908A4
Authority
EP
European Patent Office
Prior art keywords
related disorders
acute coronary
ischemic syndrome
associated therapy
coronary ischemic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99911208A
Other languages
German (de)
English (en)
Other versions
EP1061908A1 (fr
Inventor
Steven A Nichtberger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9815857.9A external-priority patent/GB9815857D0/en
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of EP1061908A1 publication Critical patent/EP1061908A1/fr
Publication of EP1061908A4 publication Critical patent/EP1061908A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP99911208A 1998-03-13 1999-03-09 Therapie associee destinee au syndrome ischemique coronarien aigu ainsi qu'a des troubles connexes Withdrawn EP1061908A4 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US7790098P 1998-03-13 1998-03-13
US77900P 1998-03-13
GB9815857 1998-07-21
GBGB9815857.9A GB9815857D0 (en) 1998-07-21 1998-07-21 Combination therapy for treating preventing or reducing the risks associated with acute coronary ischemic syndrome and related conditions
PCT/US1999/005063 WO1999045913A1 (fr) 1998-03-13 1999-03-09 Therapie associee destinee au syndrome ischemique coronarien aigu ainsi qu'a des troubles connexes

Publications (2)

Publication Number Publication Date
EP1061908A1 EP1061908A1 (fr) 2000-12-27
EP1061908A4 true EP1061908A4 (fr) 2007-01-24

Family

ID=26314085

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99911208A Withdrawn EP1061908A4 (fr) 1998-03-13 1999-03-09 Therapie associee destinee au syndrome ischemique coronarien aigu ainsi qu'a des troubles connexes

Country Status (4)

Country Link
EP (1) EP1061908A4 (fr)
JP (1) JP2002506024A (fr)
CA (1) CA2322824A1 (fr)
WO (1) WO1999045913A1 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6184248B1 (en) * 1996-09-05 2001-02-06 Robert K. K. Lee Compositions and methods for treatment of neurological disorders and neurodegenerative diseases
US7608640B2 (en) 1999-03-02 2009-10-27 Jallal Messadek Glycine betaine and its use
US6794412B1 (en) 1999-03-11 2004-09-21 Bristol-Myers Squibb Pharma Company Treatment of thrombosis by combined use of a factor Xa inhibitor and aspirin
EA200100966A1 (ru) * 1999-03-11 2002-02-28 Дюпон Фармасьютикалз Компани ЛЕЧЕНИЕ ТРОМБОЗА КОМБИНИРОВАННЫМ ПРИМЕНЕНИЕМ ИНГИБИТОРА ФАКТОРА Xa И АСПИРИНА, АКТИВАТОРА ТКАНЕВОГО ПЛАЗМИНОГЕНА (TPA), АНТАГОНИСТА GPIIB/IIIA, НИЗКОМОЛЕКУЛЯРНОГО ГЕПАРИНА ИЛИ ГЕПАРИНА
CA2432642A1 (fr) 2000-12-21 2002-08-08 Subhash P. Khanapure Composes aryle substitues en tant que nouveaux inhibiteurs selectifs de la cyclo-oxygenase-2, compositions et methodes d'utilisation
BE1015608A6 (fr) 2003-07-15 2005-06-07 Messadek Jallal Traitement des arterites.
ATE487494T1 (de) * 2002-11-25 2010-11-15 Jallal Messadek Betain und salicylsäure zusammensetzungen
JP2004189711A (ja) * 2002-12-11 2004-07-08 Raul Altman 急性冠動脈症候群および関連病態の治療のための抗血小板薬と組合せたメロキシカムの使用
US7371759B2 (en) 2003-09-25 2008-05-13 Bristol-Myers Squibb Company HMG-CoA reductase inhibitors and method
TW200517114A (en) * 2003-10-15 2005-06-01 Combinatorx Inc Methods and reagents for the treatment of immunoinflammatory disorders
US7420059B2 (en) 2003-11-20 2008-09-02 Bristol-Myers Squibb Company HMG-CoA reductase inhibitors and method
WO2006050581A2 (fr) 2004-11-10 2006-05-18 Jallal Messadek Betaine en tant qu'agent de lutte contre des maladies transmises par des arthropodes ou des moustiques
WO2006086856A1 (fr) 2005-02-15 2006-08-24 Messadek, Jallal Compositions therapeutiques combinees et leurs procedes d’utilisation
CN101180073A (zh) 2005-04-27 2008-05-14 贾拉尔·梅萨德克 胰岛素组合

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2105988A (en) * 1981-09-18 1983-04-07 Rocador Sa Anti-platelet aggregation dipyridamole with Al aspirin
WO1997021445A1 (fr) * 1995-12-12 1997-06-19 Omeros Medical Systems, Inc. Solution d'irrigation vasculaire et methode d'inhibition de la douleur, de l'inflammation, du spasme et de la restenose
WO1997029753A1 (fr) * 1996-02-19 1997-08-21 Sanofi Nouvelles associations de principes actifs contenant du clopidogrel et un antithrombotique
WO1997038986A1 (fr) * 1996-04-12 1997-10-23 G.D. Searle & Co. Derives benzenesulfonamide substitue utilisables comme precurseurs des inhibiteurs du cox-2
WO1997044027A1 (fr) * 1996-05-17 1997-11-27 Merck & Co., Inc. Compositions de traitement journalier monodose de maladies a mediation cyclooxygenase-2
WO1997044028A1 (fr) * 1996-05-17 1997-11-27 Merck & Co., Inc. Compositions pour traitement journalier monodose de maladies a mediateur cyclooxygenase-2
WO1997045420A1 (fr) * 1996-05-31 1997-12-04 Merck & Co., Inc. Procede pour la fabrication d'heterocycles de phenyle utiles comme inhibiteurs de la cyclo-oxygenase-2 (cox-2)
WO1998000416A1 (fr) * 1996-07-03 1998-01-08 Merck & Co., Inc. Procede de preparation d'heterocycles de phenyle utiles en tant qu'inhibiteurs de cox-2

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5239113A (en) * 1991-10-15 1993-08-24 Monsanto Company Substituted β-amino acid derivatives useful as platelet aggregation inhibitors and intermediates thereof
US5250679A (en) * 1991-10-18 1993-10-05 Genentech, Inc. Nonpeptidyl platelet aggregation inhibitors having specificity for the GPIIb III.sub. receptor
UA57002C2 (uk) * 1995-10-13 2003-06-16 Мерк Фросст Кенада Енд Ко./Мерк Фросст Кенада Енд Сі. Похідне (метилсульфоніл)феніл-2-(5н)-фуранону, фармацевтична композиція та спосіб лікування
IT1276071B1 (it) * 1995-10-31 1997-10-24 Nicox Ltd Compositi ad attivita' anti-infiammatoria
AU2202397A (en) * 1996-03-28 1997-10-17 G.D. Searle & Co. Iib/iiia antagonists co-administered with aspirin and/or heparin
HU224315B1 (hu) * 1996-06-05 2005-07-28 Gyógyszerkutató Intézet Kft. Véralvadásgátló hatású peptidil-arginin-aldehid-származékok és a vegyületeket tartalmazó gyógyszerkészítmények
BRPI9710372B8 (pt) * 1996-07-18 2021-05-25 Merck Canada Inc composto, e, composição farmacêutica.

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2105988A (en) * 1981-09-18 1983-04-07 Rocador Sa Anti-platelet aggregation dipyridamole with Al aspirin
WO1997021445A1 (fr) * 1995-12-12 1997-06-19 Omeros Medical Systems, Inc. Solution d'irrigation vasculaire et methode d'inhibition de la douleur, de l'inflammation, du spasme et de la restenose
WO1997029753A1 (fr) * 1996-02-19 1997-08-21 Sanofi Nouvelles associations de principes actifs contenant du clopidogrel et un antithrombotique
WO1997038986A1 (fr) * 1996-04-12 1997-10-23 G.D. Searle & Co. Derives benzenesulfonamide substitue utilisables comme precurseurs des inhibiteurs du cox-2
WO1997044027A1 (fr) * 1996-05-17 1997-11-27 Merck & Co., Inc. Compositions de traitement journalier monodose de maladies a mediation cyclooxygenase-2
WO1997044028A1 (fr) * 1996-05-17 1997-11-27 Merck & Co., Inc. Compositions pour traitement journalier monodose de maladies a mediateur cyclooxygenase-2
WO1997045420A1 (fr) * 1996-05-31 1997-12-04 Merck & Co., Inc. Procede pour la fabrication d'heterocycles de phenyle utiles comme inhibiteurs de la cyclo-oxygenase-2 (cox-2)
WO1998000416A1 (fr) * 1996-07-03 1998-01-08 Merck & Co., Inc. Procede de preparation d'heterocycles de phenyle utiles en tant qu'inhibiteurs de cox-2

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9945913A1 *

Also Published As

Publication number Publication date
EP1061908A1 (fr) 2000-12-27
JP2002506024A (ja) 2002-02-26
WO1999045913A1 (fr) 1999-09-16
CA2322824A1 (fr) 1999-09-16

Similar Documents

Publication Publication Date Title
EP1061908A4 (fr) Therapie associee destinee au syndrome ischemique coronarien aigu ainsi qu'a des troubles connexes
EP0788359A4 (fr) Compositions utiles a la preparation de medicaments destines au traitement de divers troubles refractaires
FR2777192B1 (fr) Composition a base d'herbes pour le traitement des maladies pulmonaires chroniques obstructives, des bronchites et des troubles respiratoires et procede de preparation de celle-ci
EP1252329A4 (fr) Hypocretine et recepteurs d'hypocretine pour la regulation du sommeil et des troubles du sommeil
ITMI950497A0 (it) Dispositivo a doccia micronizzata per il lavaggio delle cavita' nasali e limitrofe
EP0765166A4 (fr) Conjugues radiomarques d'annexine-galactose
ITBS990076A0 (it) Vibrostimolatore per un'azione efficace su disturbi e dolori della testa.
EP1284723A4 (fr) Compositions et methodes pour traiter des troubles associes a l'hyperlipidemie
FR2747548B1 (fr) Structure a montage tournant pour la presentation d'elements decoratifs
NO982473D0 (no) 5'-Deoksy-cytidinderivater
ITMI940884A0 (it) Medicamento topico ad attivita' cicatrizzante
EP1060748A4 (fr) Medicaments destines aux troubles de l'epithelium corneen
EP1318822A4 (fr) Therapie d'implantation cellulaire destinee aux troubles ou maladies neurologiques
FR2715848B1 (fr) Préparation d'émulsions phytothérapiques à visée topique.
FR2741903B1 (fr) Portion de palissade et palissade comprenant au moins deux de ces portions
FR2720623B1 (fr) Plaque d'ostéotomie d'ouverture.
FR2716623B1 (fr) Utilisation d'un dérivé tricyclique pour l'obtention de médicaments destinés au traitement des troubles mnémo-cognitifs.
USD375770S (en) Skater support device
FR2773074B1 (fr) Composition a base d'alpha-hydroxy-acides et de ceramides utilisable par voie topique pour le traitement d'affections dermatologiques
FR2790388B1 (fr) Compositions pharmaceutiques comprenant un benzamide et au moins un promoteur d'absorption
EP1245236A4 (fr) Produits therapeutiques et prophylactiques pour l'hepatique chronique
FR2737547B1 (fr) Tuyau forme d'au moins deux gaines concentriques
BR9909868A (pt) Ascorbato de paroxetina
FR2732219B1 (fr) Compositions pharmaceutiques pour la prevention et le traitement du paludisme, a base d'un membre de la famille des chondroitine-glycosaminoglycanes
FR2715075B1 (fr) Dispositif d'aide au mouvement des pieds.

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20001013

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU NL PT SE

AX Request for extension of the european patent

Free format text: AL PAYMENT 20001013;LT PAYMENT 20001013;LV PAYMENT 20001013;MK PAYMENT 20001013;RO PAYMENT 20001013;SI PAYMENT 20001013

A4 Supplementary search report drawn up and despatched

Effective date: 20061227

17Q First examination report despatched

Effective date: 20070810

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20080221